John Stoltzfus, Oppenheimer chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss how market could ...

While the song’s backstory might be staged on its cover - a recreation of the moment Harry Houdini was supposedly passed a ...

Analysts led by Edward Yang said Camtek is most lauded for high-resolution 3D inspection tools that boost AI chip yields by ...

DoorDash (NASDAQ:DASH) is on the path to reach $4.5B in EBITDA in 2027, thanks to increased spending on advertising and the ...

Filmmaker James Cameron calls "Oppenheimer" a "moral cop-out" for avoiding bombing aftermath scenes, as he develops his own ...

Filmmaker James Cameron has a critique of fellow director Christopher Nolan’s award-winning film, Oppenheimer.

“Yeah…it’s interesting what he stayed away from,” Cameron, 70, told Deadline of Nolan, 54, when asked if he was surprised Oppenheimer won seven Oscars and grossed nearly $1 billion. “Look, I love the ...

Revolution Medicines, Inc. (NASDAQ:RVMD) ranks among the 30 stocks expected to beat the market by 20 percentage points this year.

James Cameron has accused Christopher Nolan's Oppenheimer of being a "moral cop-out", adding that he felt as if the subject ...

James Cameron addressed Christopher Nolan's Oppenheimer, saying that the film was a 'moral cop out' due to a lack of certain ...

The teaser, which is 70 seconds long, briefly shows Matt Damon’s lead character Odysseus, his son Telemachus (played by Tom ...